PROBLEM/RATIONALE: Tumor growth in athymic nude mice is one of the most important experimental tools used to study the biology and treatment of human cancer. Until recently, it was felt this methodology suffered from the failure of such xenografts to metastasize, or to do so in a clinically relevant manner. This problem has been partly overcome, for some types of tumors, with the implementation of orthotopic transplantation techniques. However, this is not the case for malignant melanomas, which rarely manifest extra-pulmonary metastases in a tissue-specific manner. A possible solution to this problem was proposed through the isolation of lectin-resistant mutants of human melanoma cells. This is based on the hypothesis that stable `tissue-specific' metastatic melanoma subpopulations exist in very low frequencies, but can be isolated and enriched through selection of certain types of Lecr mutants, i.e. cells which possess specific alterations in cell surface glycoconjugates. RECENT FINDINGS/EXPERIMENTAL APPROACH: Using a long-term multi- step selection protocol several remarkable spontaneous wheat germ agglutinin-resistant (WGRr) variant sublines of a human melanoma cell line (MeWo) were recently isolated. One of these (70-W) manifested multiple bilateral cerebral, skin, abdominal, gut and lung metastases after iv inoculation of the cells. Moreover, the metastases were always intensely melanotic, in contrast to the MeWo parent - which is mostly amelanotic and metastasizes exclusively to the lungs. A second WGAr subline (3S5) was obtained which was found to be virtually devoid of pulmonary metastatic capacity. Both were found to be phenotypically stable for prolonged periods in culture in the absence of WGA. LONG-TERM OBJECTIVES AND SIGNIFICANCE: The availability of these and new variants presents a unique opportunity to rigorously analyze the genetic, biochemical, and biological basis of human malignant melanoma metastasis and its experimental treatment. Furthermore, their behavior increases the likelihood that the results will be relevant to melanoma in man. The long-term objective of the proposed studies is to determine the basis for the malignant characteristics of the cell lines. Experiments are proposed to genetically characterize the variants using somatic cell and molecular genetic, including gene transfer, technology. Biochemical analysis will be undertaken to determine the nature of glycosylation changes in the cells and their functional significance. Finally, on the basis of several hypotheses, attempts will be made to identify the existence of tissue-specific growth factors, or adhesion molecules which may help determine the metastatic tissue trophism of the 70-W variant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA041233-04
Application #
3181506
Study Section
Pathology B Study Section (PTHB)
Project Start
1986-01-01
Project End
1991-12-31
Budget Start
1989-01-01
Budget End
1989-12-31
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Mount Sinai Hospital (Toronto)
Department
Type
DUNS #
City
Toronto
State
ON
Country
Canada
Zip Code
Finer-Moore, Janet S; Lee, Tom T; Stroud, Robert M (2018) A Single Mutation Traps a Half-Sites Reactive Enzyme in Midstream, Explaining Asymmetry in Hydride Transfer. Biochemistry 57:2786-2795
Kerbel, Robert S (2015) A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment. Cancer J 21:274-83
Kuczynski, Elizabeth A; Lee, Christina R; Man, Shan et al. (2015) Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma. Cancer Res 75:2510-9
Cruz-Muñoz, William; Di Desidero, Teresa; Man, Shan et al. (2014) Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer. Angiogenesis 17:661-73
Kerbel, Robert S; Guerin, Eric; Francia, Giulio et al. (2013) Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis. Breast 22 Suppl 2:S57-65
Guerin, Eric; Man, Shan; Xu, Ping et al. (2013) A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs. Cancer Res 73:2743-8
Hackl, Christina; Man, Shan; Francia, Giulio et al. (2013) Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models. Gut 62:259-71
Milsom, Chloe C; Lee, Christina R; Hackl, Christina et al. (2013) Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2R?(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis. PLoS One 8:e71270
Kuczynski, Elizabeth A; Sargent, Daniel J; Grothey, Axel et al. (2013) Drug rechallenge and treatment beyond progression--implications for drug resistance. Nat Rev Clin Oncol 10:571-87
Cruz-Muñoz, William; Jaramillo, Maria L; Man, Shan et al. (2012) Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma. Cancer Res 72:4909-19

Showing the most recent 10 out of 111 publications